Wakefit Innovations Limited reported a strong start to FY27, with revenue from operations rising 16.6% year-on-year to ₹4,049.1 million in the quarter ended June 30, 2026. The Bengaluru-based direct-to-consumer home furnishings company saw its profit after tax (PAT) increase by 19.2% to ₹233.8 million, driven by improved operational efficiency and strategic price adjustments that offset raw material volatility linked to Middle East geopolitical tensions. This performance highlights the company's ability to expand margins amidst supply chain headwinds.

The results were filed under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, on August 06, 2026. The Board of Directors approved the unaudited financials, reviewed by Statutory Auditors M/s. B S R & Co. LLP under Standard on Review Engagements (SRE) 2410. Reported EBITDA (excluding other income) grew 25.2% to ₹564.0 million, while operating EBITDA surged 49.7% to ₹368.3 million.

Financial Performance

The following table summarises Wakefit Innovations' key financial metrics for Q1FY27 compared to Q1FY26:

Gross profit stood at ₹2,310.9 million, representing a margin of 57.1%, an improvement from 55.8% in the corresponding quarter last year. This uplift was primarily driven by price hikes implemented to counter sharp increases in Polyol and TDI prices due to supply disruptions. Other income contributed ₹156.2 million to total income. ESOP expenses for the quarter stood at ₹6.1 million.

Operational Highlights

Mattresses contributed 65.9% of total sales, followed by furniture at 27.8% and furnishings at 6.3%. Own channels accounted for 72.3% of revenue, growing 20.5% year-on-year, while external channels grew 7.6%. Retail channel growth mirrored this trend at 20.5% YoY.

Wakefit Innovations expanded its physical footprint significantly, adding 27 new COCO stores during the quarter to reach a total of 165 active stores as of June 30, 2026. This pace is notably higher than the 42 stores added throughout all of FY26. Additionally, the Managed Business Operator (MBO) network expanded to 2,250 stores across 701 cities. Advertisement and marketing investments remained stable at 7.6% of revenue.

What the Numbers Show

The divergence between reported PAT growth (19.2%) and operating EBITDA growth (49.7%) highlights the impact of tax accounting adjustments rather than pure operational leverage. The current quarter included a deferred tax expense of ₹73.0 million due to the partial unwinding of deferred tax assets (DTA). This contrasts sharply with Q4FY26, which benefited from a one-time DTA recognition of ₹980.7 million. Excluding these tax movements, underlying PAT was ₹306.8 million, indicating that core operational profitability remained stable with only a marginal 1.9% YoY increase. This suggests that while top-line growth is accelerating, the normalization of tax benefits has temporarily muted net profit visibility compared to the prior year's exceptional quarter.

Management Commentary

Ankit Garg, Chairman, CEO and Executive Director, noted that repeat customers contributed 36.7% of revenue, underscoring strong brand loyalty. He highlighted that the mattress business grew 27.3% YoY and remains the primary cash-generation engine. Looking ahead, management expects furniture and furnishings to gain meaningful contribution over the next three to four years.

Chaitanya Ramalingegowda, Executive Director, addressed the supply chain challenges caused by Middle East-related volatility in raw material costs. He confirmed that calibrated pricing actions mitigated immediate impacts, though full cost pressures may reflect in H1FY27. The company remains on track for its planned capex of ₹1,000–1,200 million, with 80% allocated to retail expansion, particularly jumbo stores, and 20% to manufacturing automation.

Wakefit Innovations has granted 4,57,611 Employee Stock Options (ESOPs) to eligible employees under its Wakefit Employee Stock Option Plan - 2019. The grant, approved by the Nomination and Remuneration Committee (NRC) on July 13, 2026, aims to incentivize employees through equity ownership in the company. The options are priced at Re. 1 per share and will convert into equity shares of the same face value upon exercise.

The allocation of these options is in compliance with the Securities and Exchange Board of India (SEBI) (Share Based Employee Benefits & Sweat Equity) Regulations, 2021. The company confirmed that the scheme adheres to the regulatory framework, ensuring that the grant process meets all necessary disclosure and compliance standards mandated by the market regulator.

Vesting and Exercise Details

The granted options come with specific vesting and exercise timelines designed to align employee interests with long-term company performance. According to the disclosure, the options will vest after a minimum period of 12 months from the Grant Date and not later than 5 years. The actual vesting will be determined based on time and/or performance criteria as outlined in the Letter of Grant, subject to the employee's continued employment.

Once vested, the options can be exercised by the employees. All vested options must be exercised within a maximum period of 1 year from the date of vesting. The company noted that vesting timelines may be extended for unauthorized or non-statutory leaves as per the provisions of the ESOP Plan.

Key Terms of the Grant

The detailed terms of the ESOP grant were disclosed in an annexure to the regulatory filing. The table below summarizes the significant particulars of the options granted:

The company stated that no options have been exercised, lapsed, or varied as of this disclosure, as the announcement pertains strictly to the initial grant. The information regarding the grant has been made available on the company's official investor relations website for shareholder reference.